Population Pharmacokinetics of Therapeutic Monoclonal Antibodies

Springer Science and Business Media LLC - Tập 49 Số 10 - Trang 633-659 - 2010
Nathanael L. Dirks1, Bernd Meibohm1
1Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Maggon, 2007, Curr Med Chem, 14, 1978, 10.2174/092986707781368504

Reichert, 2008 Dec, Curr Pharm Biotechnol, 9, 423, 10.2174/138920108786786358

Galluppi, 2001 Jun, Clin Pharmacol Ther, 69, 387, 10.1067/mcp.2001.115455

Meibohm, 2006, 3

Meibohm, 2002 Jan, J Pharm Sci, 91, 18, 10.1002/jps.1167

Kuester, 2006, 45

Lobo, 2004 Nov, J Pharm Sci, 93, 2645, 10.1002/jps.20178

Tabrizi, 2006 Jan, Drug Discov Today, 11, 81, 10.1016/S1359-6446(05)03638-X

Wang, 2008 Nov, Clin Pharmacol Ther, 84, 548, 10.1038/clpt.2008.170

Roitt, 2006

Mascelli, 2007 May, J Clin Pharmacol, 47, 553, 10.1177/0091270006298360

Bonate, 2005, AAPS J, 7, E363, 10.1208/aapsj070237

Bonate, 2006

Ette, 2004 Oct, Ann Pharmacother, 38, 1702, 10.1345/aph.1D374

Ette, 2007

Sheiner, 1992, Annu Rev Pharmacol Toxicol, 32, 185, 10.1146/annurev.pa.32.040192.001153

Mould, 2007 Sep, Br J Clin Pharmacol, 64, 278, 10.1111/j.1365-2125.2007.02914.x

Zingmark, 2004 Oct, Br J Clin Pharmacol, 58, 378, 10.1111/j.1365-2125.2004.02177.x

Mentré, 1999 Apr, J Pharmacokinet Biopharm, 27, 213, 10.1023/A:1020658023774

Kovarik, 2001 Apr, Clin Pharmacol Ther, 69, 201, 10.1067/mcp.2001.114887

Lu, 2008 Oct, Cancer Chemother Pharmacol, 62, 779, 10.1007/s00280-007-0664-8

Dirks, 2008 Mar, J Clin Pharmacol, 48, 267, 10.1177/0091270007313393

Mould, 1999 Sep, Clin Pharmacol Ther, 66, 246, 10.1016/S0009-9236(99)70032-9

Ng, 2005 Jul, Pharm Res, 22, 1088, 10.1007/s11095-005-5642-4

Sun, 2005 Apr, J Clin Pharmacol, 45, 468, 10.1177/0091270004272731

Zhou, 2007 Mar, J Clin Pharmacol, 47, 383, 10.1177/0091270006298188

Bauer, 1999 Aug, J Pharmacokinet Biopharm, 27, 397, 10.1023/A:1020917122093

Fang, 2007 Feb, J Clin Pharmacol, 47, 227, 10.1177/0091270006293758

Xu, 2008 Jun, J Clin Pharmacol, 48, 681, 10.1177/0091270008316886

Fasanmade, 2009, Eur J Clin Pharmacol, 65, 1211, 10.1007/s00228-009-0718-4

Dartois, 2007, Clin Pharmacokinet, 46, 417, 10.2165/00003088-200746050-00004

Tanswell, 2001 Feb, Br J Clin Pharmacol, 51, 177, 10.1111/j.1365-2125.2001.01335.x

Kuester, 2008 Mar 11, Br J Cancer, 98, 900, 10.1038/sj.bjc.6604265

Hayashi, 2007 May, Br J Clin Pharmacol, 63, 548, 10.1111/j.1365-2125.2006.02803.x

Ma, 2009 Oct, J Clin Pharmacol, 49, 1142, 10.1177/0091270009344989

Ng, 2006 Jun, Pharm Res, 23, 1275, 10.1007/s11095-006-0205-x

Ng, 2005 Jul, J Clin Pharmacol, 45, 792, 10.1177/0091270005277075

Kloft, 2004 Jan, Invest New Drugs, 22, 39, 10.1023/B:DRUG.0000006173.72210.1c

Bruno, 2005 Oct, Cancer Chemother Pharmacol, 56, 361, 10.1007/s00280-005-1026-z

Zhu, 2009 Feb, J Clin Pharmacol, 49, 162, 10.1177/0091270008329556

Pescovitz, 2008 Jun, Pediatr Transplant, 12, 447, 10.1111/j.1399-3046.2007.00830.x

Meissner, 1999 May, Antimicrob Agents Chemother, 43, 1183, 10.1128/AAC.43.5.1183

Beal, 2006

Ternant, 2008 Aug, Ther Drug Monit, 30, 523, 10.1097/FTD.0b013e318180e300

Supersaxo, 1990 Feb, Pharm Res, 7, 167, 10.1023/A:1015880819328

McLennan, 2005 Apr, J Pharmacol Exp Ther, 313, 345, 10.1124/jpet.104.078790

Kagan, 2007 Nov, Eur J Pharm Biopharm, 67, 759, 10.1016/j.ejpb.2007.04.002

OʼDriscoll, 1992, 1

Garg, 2007 Oct, J Pharmacokinet Pharmacodyn, 34, 687, 10.1007/s10928-007-9065-1

Tabrizi, 2010 Mar, AAPS J, 12, 33, 10.1208/s12248-009-9157-5

Ghetie, 1997 Dec, Immunol Today, 18, 592, 10.1016/S0167-5699(97)01172-9

Ward, 2003 Feb, Int Immunol, 15, 187, 10.1093/intimm/dxg018

Antohe, 2001 Feb, Hum Immunol, 62, 93, 10.1016/S0198-8859(00)00244-5

Claypool, 2002 Aug 2, J Biol Chem, 277, 28038, 10.1074/jbc.M202367200

Dickinson, 1999 Oct, J Clin Invest, 104, 903, 10.1172/JCI6968

Kobayashi, 2002 Feb, Am J Physiol Renal Physiol, 282, F358, 10.1152/ajprenal.0164.2001

McCarthy, 2000 Apr, J Cell Sci, 113, 1277, 10.1242/jcs.113.7.1277

Praetor, 1999 Jul, J Cell Sci, 112, 2291, 10.1242/jcs.112.14.2291

Tuma, 2003 Jul, Physiol Rev, 83, 871, 10.1152/physrev.00001.2003

Tang, 2004 Sep, J Pharm Sci, 93, 2184, 10.1002/jps.20125

Waldmann, 1969, Prog Allergy, 13, 1

Straughn, 2006, 181

Lote, 2000

Wu, 2004 Sep-Dec, Clin Dev Immunol, 11, 205, 10.1080/17402520400004177

Brambell, 1966 Nov 19, Lancet, 2, 1087, 10.1016/S0140-6736(66)92190-8

Junghans, 1997 Feb, Immunol Res, 16, 29, 10.1007/BF02786322

Ober, 2004 Feb 15, J Immunol, 172, 2021, 10.4049/jimmunol.172.4.2021

Morell, 1970 Apr, J Clin Invest, 49, 673, 10.1172/JCI106279

Kim, 2007 Feb, Clin Immunol, 122, 146, 10.1016/j.clim.2006.09.001

Daba, 2007

Roopenian, 2007 Sep, Nat Rev Immunol, 7, 715, 10.1038/nri2155

Sigal, 2007 Dec, J Clin Rheumatol, 13, 355, 10.1097/RHU.0b013e31815c5ecd

Levy, 1994 Sep, Clin Pharmacol Ther, 56, 248, 10.1038/clpt.1994.134

Mager, 2006 Jun 28, Biochem Pharmacol, 72, 1, 10.1016/j.bcp.2005.12.041

Marathe, 2008 Aug, J Pharmacol Exp Ther, 326, 555, 10.1124/jpet.108.137703

Tabrizi, 2006, 295

Tan, 2006 Nov 1, Clin Cancer Res, 12, 6517, 10.1158/1078-0432.CCR-06-0705

Baselga, 2000 Feb, J Clin Oncol, 18, 904, 10.1200/JCO.2000.18.4.904

Tokuda, 1999 Dec, Br J Cancer, 81, 1419, 10.1038/sj.bjc.6690343

Godfrey, 1994 Jun, J Pharmacokinet Biopharm, 22, 229, 10.1007/BF02353330

Gibiansky, 2009 Jul, Expert Opin Drug Metab Toxicol, 5, 803, 10.1517/17425250902992901

Gibiansky, 2008 Oct, J Pharmacokinet Pharmacodyn, 35, 573, 10.1007/s10928-008-9102-8

Khosla, 2001 Dec, Endocrinology, 142, 5050, 10.1210/endo.142.12.8536

Lewiecki, 2008 Dec, Biologics, 2, 645

Cohenuram, 2007 Jan, Anticancer Drugs, 18, 7, 10.1097/CAD.0b013e32800feecb

Kim, 2008 Jun, Biologics, 2, 223

Vanhoefer, 2004 Jan 1, J Clin Oncol, 22, 175, 10.1200/JCO.2004.05.114

Ober, 2001 Dec, Int Immunol, 13, 1551, 10.1093/intimm/13.12.1551

Kovarik, 1998 Jul, Clin Pharmacol Ther, 64, 66, 10.1016/S0009-9236(98)90024-8

Cartron, 2002 Feb 1, Blood, 99, 754, 10.1182/blood.V99.3.754

Weng, 2003 Nov 1, J Clin Oncol, 21, 3940, 10.1200/JCO.2003.05.013

Louis, 2004 Mar 1, Aliment Pharmacol Ther, 19, 511, 10.1111/j.1365-2036.2004.01871.x

Musolino, 2008 Apr 10, J Clin Oncol, 26, 1789, 10.1200/JCO.2007.14.8957

Meibohm, 2005, AAPS J, 7, E475, 10.1208/aapsj070248

Wang, 2009 Sep, J Clin Pharmacol, 49, 1012, 10.1177/0091270009337512

Seitz, 2007 Sep, J Clin Pharmacol, 47, 1104, 10.1177/0091270007306958

de Bono, 2004 Nov 15, Clin Cancer Res, 10, 7555, 10.1158/1078-0432.CCR-04-0729

Roskos, 2005, 172

Mahmood, 2005, Clin Pharmacokinet, 44, 331, 10.2165/00003088-200544040-00001

Anderson, 2006 Jul, Trends Immunol, 27, 343, 10.1016/j.it.2006.05.004